These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8750651)

  • 1. Third-generation PSA: ultrasensitive or ultraprecise assay?
    Mione R; Barichello M; Sartorello P; Leon A; Barioli P; Gion M
    Int J Biol Markers; 1995; 10(4):229-33. PubMed ID: 8750651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers.
    Ferguson RA; Yu H; Kalyvas M; Zammit S; Diamandis EP
    Clin Chem; 1996 May; 42(5):675-84. PubMed ID: 8653891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up.
    Vassilikos EJ; Yu H; Trachtenberg J; Nam RK; Narod SA; Bromberg IL; Diamandis EP
    Clin Biochem; 2000 Mar; 33(2):115-23. PubMed ID: 10751589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.
    Haese A; Huland E; Graefen M; Hammerer P; Noldus J; Huland H
    J Urol; 1999 Apr; 161(4):1206-11. PubMed ID: 10081870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen.
    Stamey TA; Graves HC; Wehner N; Ferrari M; Freiha FS
    J Urol; 1993 Apr; 149(4):787-92. PubMed ID: 7681119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supersensitive PSA-analysis after radical prostatectomy: a powerful tool to reduce the time gap between surgery and evidence of biochemical failure.
    Haese A; Huland E; Graefen M; Huland H
    Anticancer Res; 1999; 19(4A):2641-4. PubMed ID: 10470210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy.
    Witherspoon LR; Lapeyrolerie T
    J Urol; 1997 Apr; 157(4):1322-8. PubMed ID: 9120931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biologic lower detection limit of six ultrasensitive PSA assays.
    Junker R; Brandt B; Semjonow A; Erren M; Zechel C; Assmann G
    Anticancer Res; 1999; 19(4A):2625-8. PubMed ID: 10470206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the nadir value of serum prostate-specific antigen measured by an ultrasensitive assay as a predictor of biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.
    Sakai I; Harada K; Kurahashi T; Muramaki M; Yamanaka K; Hara I; Inoue TA; Miyake H
    Urol Int; 2006; 76(3):227-31. PubMed ID: 16601384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.
    Shen S; Lepor H; Yaffee R; Taneja SS
    J Urol; 2005 Mar; 173(3):777-80. PubMed ID: 15711268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technology.
    Wilson DH; Hanlon DW; Provuncher GK; Chang L; Song L; Patel PP; Ferrell EP; Lepor H; Partin AW; Chan DW; Sokoll LJ; Cheli CD; Thiel RP; Fournier DR; Duffy DC
    Clin Chem; 2011 Dec; 57(12):1712-21. PubMed ID: 21998342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasensitive assay of prostate-specific antigen for early detection of residual cancer after radical prostatectomy.
    Arai Y; Okubo K; Aoki Y; Maekawa S; Okada T; Maeda H
    Int J Urol; 1998 Nov; 5(6):550-5. PubMed ID: 9855123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of a Fifth-Generation Ultrasensitive Prostate-Specific Antigen Assay for Monitoring Prostate Cancer Patients after Radical Prostatectomy with 3 Years of Follow-Up.
    Ren AH; Soosaipillai A; Mathew A; Nikolenko G; Sardesai L; Stengelin M; Diamandis EP
    Clin Chem; 2020 Oct; 66(10):1329-1338. PubMed ID: 33001184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic acid detection immunoassay for prostate-specific antigen based on immuno-PCR methodology.
    McDermed JE; Sanders R; Fait S; Klem RE; Sarno MJ; Adams TH; Diamandis EP
    Clin Chem; 2012 Apr; 58(4):732-40. PubMed ID: 22361936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of serum prostate specific antigen using IMx prostate specific antigen assay.
    Klee GG; Dodge LA; Zincke H; Oesterling JE
    J Urol; 1994 Jan; 151(1):94-8. PubMed ID: 7504749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen.
    Black MH; Magklara A; Obiezu CV; Melegos DN; Diamandis EP
    Clin Chem; 1999 Jun; 45(6 Pt 1):790-9. PubMed ID: 10351987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of ultrasensitive prostate-specific antigen assay for early detection of biochemical failure after radical prostatectomy.
    Nakamura M; Hasumi H; Miyoshi Y; Sugiura S; Fujinami K; Yao M; Kubota Y; Uemura H
    Int J Urol; 2005 Dec; 12(12):1050-4. PubMed ID: 16409609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a highly sensitive immunochemiluminometric assay for prostate-specific antigen.
    Klee GG; Preissner CM; Oesterling JE
    Urology; 1994 Jul; 44(1):76-82. PubMed ID: 7518985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of hyper sensitive PSA assay kits for determination on low range of prostate specific antigen in prostate cancer].
    Akimoto S; Akakura K; Ohki T; Shimazaki J; Kuriyama M; Kawada Y
    Nihon Hinyokika Gakkai Zasshi; 1995 Feb; 86(2):256-62. PubMed ID: 7534843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of 'ultrasensitive' prostate-specific antigen assays in the detection of biochemical recurrence after radical prostatectomy.
    van Iersel MP; Thomas CM; Segers MF; Witjes WP; Debruyne FM; Oosterhof GO
    Br J Urol; 1996 Mar; 77(3):418-22. PubMed ID: 8814849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.